BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
CNN – In just five years, the number of small children in the US exposed to cannabis after accidentally eating an edible rose 1,375%, a new study says. There were more than 7,040 exposures to edible cannabis in kids under 6 between 2017 and 2021, according to an analysis of records from the National Poison Data
Increased marijuana poisoning in children follows increased availability and increased potency. Visit any cannabis store in person or on-line and you will find concentrates at over 90% THC. High potency THC can behave like a hard drug, like methamphetamine. Dosing in children is a major concern. One gummy of 10 mg THC for an adult can cause psychosis. For a child it can cause altered mental status, encephalopathy, or delirium.
A 2-year-old boy presents to the pediatric emergency department (ED) for altered mental status. Prior to arrival, he was with his babysitter in a normal state of health. After questioning, the babysitter mentions rewarding him with a gummy candy for good behavior. The parents admit they have edible cannabis stored in the cupboard that looks
Six students were taken to the hospital after eating cannabis-laced Cheetos at a California elementary school on Thursday, several outlets reported. KTLA reported that deputies from the Riverside County Sheriff’s Department responded to a call about students suffering from food-related illnesses at Enchanted Elementary School in Perris, California, at around 11:30 a.m.. An investigation showed
Cannabis (marijuana) is one of the most abused drugs worldwide. The past decade has seen an increase in the legalization of cannabis for both medicinal and recreational use. As of June 2021, 36 states allow the use of cannabis for medicinal purposes, and that number is expected to increase with additional states considering legalization in
Officials from the Hudson Valley continue to worry after a number of high school students were hospitalized from marijuana use. Last week, several Pine Bush High School students were transported to the hospital due to drug use. “The health consequences were serious, but they have recovered and are getting support from their families,” Pine Bush’s interim
Police responded to Bloomfield High School at 10:48 a.m. Thursday following reports of an apparent drug overdose. The 16-year-old student was given first aid by responding officers and staff, including “administering multiple doses” of Narcan, which is used to counteract the effects of an opioid overdose. He was transported to Connecticut Children’s Medical Center and
Multiple states have passed legislation permitting marijuana use. The impact of legalization on trends in hospital encounters for marijuana exposures in young children across states remains unknown. This study, published in Academic Pediatrics in July 2021, aims to describe trends in marijuana-related hospital encounters over time in children <6 years and assess the association of
Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations
IASIC supports protecting the growing brain until age 25-27 as well as awareness of many health concerns associated with marijuana. See the full article here
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
